Literature DB >> 20385548

Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.

Giorgio Cavigiolio1, Ethan G Geier, Baohai Shao, Jay W Heinecke, Michael N Oda.   

Abstract

An important event in cholesterol metabolism is the efflux of cellular cholesterol by apolipoprotein A-I (apoA-I), the major protein of high density lipoproteins (HDL). Lipid-free apoA-I is the preferred substrate for ATP-binding cassette A1, which promotes cholesterol efflux from macrophage foam cells in the arterial wall. However, the vast majority of apoA-I in plasma is associated with HDL, and the mechanisms for the generation of lipid-free apoA-I remain poorly understood. In the current study, we used fluorescently labeled apoA-I that exhibits a distinct fluorescence emission spectrum when in different states of lipid association to establish the kinetics of apoA-I transition between the lipid-associated and lipid-free states. This approach characterized the spontaneous and rapid exchange of apoA-I between the lipid-associated and lipid-free states. In contrast, the kinetics of apoA-I exchange were significantly reduced when apoA-I on HDL was cross-linked with a bi-functional reagent or oxidized by myeloperoxidase. Our observations support the hypothesis that oxidative damage to apoA-I by myeloperoxidase limits the ability of apoA-I to be liberated in a lipid-free form from HDL. This impairment of apoA-I exchange reaction may be a trait of dysfunctional HDL contributing to reduced ATP-binding cassette A1-mediated cholesterol efflux and atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20385548      PMCID: PMC2881807          DOI: 10.1074/jbc.M109.098434

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  92 in total

Review 1.  What is so special about apolipoprotein AI in reverse cholesterol transport?

Authors:  Linda K Curtiss; David T Valenta; Neil J Hime; Kerry-Anne Rye
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-03       Impact factor: 8.311

Review 2.  Molecular regulation of macrophage reverse cholesterol transport.

Authors:  Xun Wang; Daniel J Rader
Journal:  Curr Opin Cardiol       Date:  2007-07       Impact factor: 2.161

Review 3.  Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins.

Authors:  Ernst Malle; Gunther Marsche; Ute Panzenboeck; Wolfgang Sattler
Journal:  Arch Biochem Biophys       Date:  2005-08-31       Impact factor: 4.013

4.  Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice.

Authors:  Miranda Van Eck; Roshni R Singaraja; Dan Ye; Reeni B Hildebrand; Erick R James; Michael R Hayden; Theo J C Van Berkel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-02-02       Impact factor: 8.311

5.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

6.  Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I.

Authors:  Baohai Shao; Michael N Oda; Constanze Bergt; Xiaoyun Fu; Pattie S Green; Nathan Brot; John F Oram; Jay W Heinecke
Journal:  J Biol Chem       Date:  2006-02-22       Impact factor: 5.157

7.  Minimal lipidation of pre-beta HDL by ABCA1 results in reduced ability to interact with ABCA1.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Michael J Thomas; Perry L Colvin; John S Parks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-17       Impact factor: 8.311

8.  Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning.

Authors:  Henry J Pownall; Brian D Hosken; Baiba K Gillard; Catherine L Higgins; Hu Yu Lin; John B Massey
Journal:  Biochemistry       Date:  2007-05-27       Impact factor: 3.162

9.  Characterization of low density lipoprotein receptor ligand interactions by fluorescence resonance energy transfer.

Authors:  Taichi Yamamoto; Johanne Lamoureux; Robert O Ryan
Journal:  J Lipid Res       Date:  2006-02-08       Impact factor: 5.922

Review 10.  The paradox of dysfunctional high-density lipoprotein.

Authors:  Benjamin J Ansell; Gregg C Fonarow; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2007-08       Impact factor: 4.776

View more
  42 in total

1.  Naturally occurring variant of mouse apolipoprotein A-I alters the lipid and HDL association properties of the protein.

Authors:  Timothy J Sontag; Ronald Carnemolla; Tomas Vaisar; Catherine A Reardon; Godfrey S Getz
Journal:  J Lipid Res       Date:  2012-03-08       Impact factor: 5.922

2.  HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.

Authors:  Mark S Borja; Kit F Ng; Angela Irwin; Jaekyoung Hong; Xing Wu; Daniel Isquith; Xue-Qiao Zhao; Bryan Prazen; Virginia Gildengorin; Michael N Oda; Tomáš Vaisar
Journal:  J Lipid Res       Date:  2015-08-07       Impact factor: 5.922

3.  Assessment of the validity of the double superhelix model for reconstituted high density lipoproteins: a combined computational-experimental approach.

Authors:  Martin K Jones; Lei Zhang; Andrea Catte; Ling Li; Michael N Oda; Gang Ren; Jere P Segrest
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

4.  Featured Article: Alterations of lecithin cholesterol acyltransferase activity and apolipoprotein A-I functionality in human sickle blood.

Authors:  Eric Soupene; Mark S Borja; Mauricio Borda; Sandra K Larkin; Frans A Kuypers
Journal:  Exp Biol Med (Maywood)       Date:  2016-06-27

5.  A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Authors:  Allison L Cooke; Jamie Morris; John T Melchior; Scott E Street; W Gray Jerome; Rong Huang; Andrew B Herr; Loren E Smith; Jere P Segrest; Alan T Remaley; Amy S Shah; Thomas B Thompson; W Sean Davidson
Journal:  J Lipid Res       Date:  2018-05-17       Impact factor: 5.922

6.  The "beta-clasp" model of apolipoprotein A-I--a lipid-free solution structure determined by electron paramagnetic resonance spectroscopy.

Authors:  Jens O Lagerstedt; Madhu S Budamagunta; Grace S Liu; Nicole C DeValle; John C Voss; Michael N Oda
Journal:  Biochim Biophys Acta       Date:  2012-01-08

7.  A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Lin Li; Xinmin S Li; Stanley L Hazen; Jonathan D Smith
Journal:  J Appl Lab Med       Date:  2020-05-01

8.  Effects of Increasing Exercise Intensity and Dose on Multiple Measures of HDL (High-Density Lipoprotein) Function.

Authors:  Mark A Sarzynski; Jonathan J Ruiz-Ramie; Jacob L Barber; Cris A Slentz; John W Apolzan; Robert W McGarrah; Melissa N Harris; Timothy S Church; Mark S Borja; Yumin He; Michael N Oda; Corby K Martin; William E Kraus; Anand Rohatgi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-02-08       Impact factor: 8.311

Review 9.  Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural Insights.

Authors:  Madhurima Das; Olga Gursky
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

Review 10.  High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; Georgette M Buga; Greg Hough; Alan C Wagner; Alan M Fogelman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.